A 52-year-old woman, 3 years into aromatase inhibitor therapy for stage I hormone receptor–positive breast cancer, reports severe vasomotor symptoms, insomnia, brain fog, arthralgias, dyspareunia, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results